(Ebook) Clinical Handbook Of Insomnia 3rd Edition by Hrayr P Attarian ISBN 3319413988 9783319413983

(Ebook) Clinical Handbook Of Insomnia 3rd Edition by Hrayr P Attarian ISBN 3319413988 9783319413983

(Ebook) Clinical Handbook Of Insomnia 3rd Edition by Hrayr P Attarian - Ebook PDF Instant Download/Delivery: 3319413988, 9783319413983
Full download (Ebook) Clinical Handbook Of Insomnia 3rd Edition after payment

Product details:

ISBN 10: 3319413988 
ISBN 13: 9783319413983
Author: Hrayr P Attarian

Expanding on the critical contributions of previous editions, this updated and comprehensive resource covers the latest diagnostic criteria of insomnia. The book is thematically divided into two parts. The first section consists of chapters on nomenclature, epidemiology, pathophysiology, diagnosis and differential diagnosis, complications and prognosis and treatment both pharmacological and behavioral. The second features chapters on insomnia in special populations, including ones on children and adolescents, cancer sufferers and survivors, in pregnancy, in menopausal women and in patients with neurological disorders and those with psychiatric illnesses.   This third edition fills an important niche in the medical literature by addressing insomnia in its multiple forms, summarizes the findings published in different medical journals, and presents these to the practicing health care provider in an easily accessible format.

(Ebook) Clinical Handbook Of Insomnia 3rd Table of contents:

Part I: Chronic Insomnia Disorder
Chapter 1: Defining Insomnia
Introduction
Historical Perspectives
Definitions of Insomnia
Classifications
Classification Based on Duration and Severity
Duration of Illness
Severity of Illness
Commonalities and Problems with Current Definitions
Insomnia as a Subjective Complaint
Insomnia and Daytime Impairment
The Old Diagnostic Entity of Comorbid or Secondary Insomnia
Summary
References
Chapter 2: Epidemiology of Insomnia
Sociodemographic Determinants
Gender
Age
Ethnocultural Factors
Shift Work
Other Factors
Psychiatric Disorders
Morbidity and Mortality
Epidemiology of Hypnotic Use
Economic Impact of Insomnia
Conclusion
References
Chapter 3: Clinical Features, Diagnosis, and Differential Diagnosis
Introduction
Clinical Features
Clinical Subtype Features
Diagnostic Workup
Differential Diagnosis
Appendix 1
References
Chapter 4: Pathophysiology of Insomnia
Introduction
Historical Studies of Insomnia
Modeling Studies of Insomnia and Physiological Activation
The Effects of Poor Sleep
Poor Sleep in Insomnia Patients
The Development of Insomnia
Medical Implications of These Physiological Arousal Data
Elevated Blood Pressure/Hypertension
Glycemic Control/Diabetes
Depression
Immune Function
Mortality
Discussion
References
Chapter 5: Prognosis and Complications
Prognosis and Complications
Psychiatric Disorders
Neurocognitive Function
Metabolic Disorders
Cardiovascular Disease
Burden of Illness
References
Chapter 6: Cognitive Behavioral Therapy for Insomnia
Theoretical Perspectives on Insomnia
Behavioral Perspective
Cognitive Perspective
Neurocognitive Perspective
Assessment and Measurement
Self-Report Assessment
Objective Assessment
Cognitive-Behavioral Treatment
Therapeutic Regimen
First-Line Interventions
Stimulus Control Therapy
Sleep Restriction
Sleep Hygiene Education
Cognitive Therapy
Relaxation Training
Phototherapy
Complicating Factors
Treatment Compliance
Comorbidity of Mental and Medical Disorders
CBT and Sedative Hypnotics
The Efficacy of CBT
Abbreviated Versions of CBT-I
Technology and CBT
Summary
References
Chapter 7: Pharmacological Treatment of Insomnia
Introduction
Key Pharmacologic Issues
Prescription and Non-prescription Agents Approved by FDA for Treatment of Insomnia
Benzodiazepine Receptor Agonists
Mechanism of Action
Pharmacokinetics
Efficacy
Safety
Residual Effects
Sedation
Driving Performance
Fall Risk
Amnesia
Complex Behaviors During Sleep
Mortality Risk
Tolerance, Dependence, Abuse Potential
Discontinuation Effects
Melatonin Receptor Agonists
Ramelteon
Melatonin
Orexin Antagonists
Histamine (H1) Antagonists
Selective H1 Antagonist: Doxepin 3–6 mg
Nonselective H1 Antagonists: Diphenhydramine, Doxylamine
Prescription Agents Used Off-Label for Treatment of Insomnia
Other BzRAS
Antidepressants
Trazodone
Mirtazapine
Tricyclic Antidepressants
Antipsychotics
Anticonvulsants
Alpha1-Adrenergic Antagonists
Melatonin
Pharmacologic Management of Insomnia
Indications for Pharmacological Treatment
Contraindications to Pharmacological Treatment
Implementing Pharmacological Treatment
Starting Treatment
Stopping Treatment
Treatment Considerations Based on Temporal Pattern of Insomnia
Difficulty with Sleep Onset Only
Difficulty with Sleep Maintenance Only
Difficulty with Both Sleep Onset and Sleep Maintenance
Treatment Considerations Based on Comorbid Conditions
Conclusion
References
Part II: Insomnia in Special Populations
Chapter 8: Insomnias of Childhood: Assessment and Treatment
Introduction
Definitions
Pathophysiology of BIC
Parental Reinforcement
Feeding Behavior
Medical Problems
Sentinel Events
Psychopathology and Temperament
Environmental and Circadian Factors
Sleep Disorders
Insomnia Pathophysiology
Assessment
Treatment
Treatment for BIC
Extinction
Positive Routines
Schedule Modification
Sleep Hygiene Training
Other Treatment Considerations
CBT-I for School-Age Children
Conclusion
References
Chapter 9: Pregnancy-Related Sleep Disturbances and Sleep Disorders
Introduction
Influence of Hormonal Changes on Sleep
Changes in Sleep Patterns and Sleep Architecture During Pregnancy
Causes of Nocturnal Arousals During Pregnancy
Restless Leg Syndrome in Pregnancy
Sleep-Disordered Breathing in Pregnancy
Implications of Insomnia During Pregnancy
Treatment of Insomnia During Pregnancy
References
Chapter 10: Insomnia and Menopause
Basic Concepts
Menopause
Pathophysiology of Menopausal Transition and Postmenopausal Period
Clinical Manifestations
Insomnia in the Climacteric
Clinical Evaluation of Insomnia in the Climacteric
Treatment of Insomnia in Postmenopausal Woman
Hormone Therapy
Sedatives/Hypnotics
Zolpidem
Eszopiclone
Ramelteon
Antidepressants
Paroxetine, Venlafaxine, and Desvenlafaxine
Escitalopram
Citalopram and Fluoxetine
Quetiapine
Mirtazapine
Gabapentin
Herbal and Nutritional Supplements
Isoflavones
Valerian Root
Pycnogenol
Phyto-Female Complex
Kampo
Cognitive Behavioral Therapy
High-Intensity Exercise
Hypnosis
Yoga
Massage
Acupuncture
Final Considerations
References
Chapter 11: Insomnia in Patients with Comorbid Medical Problems
Introduction
Cardiovascular Disease and Insomnia
Pulmonary Disease and Insomnia
Renal Disease and Insomnia
Gastrointestinal Disorders and Insomnia
Genitourinary Conditions and Insomnia
Endocrine Conditions and Insomnia
Ocular Disorders and Insomnia
Dermatologic Disorders and Insomnia
Cancer and Insomnia
References
Chapter 12: Sleep Disturbance in Cancer Survivors
Introduction
Sleep Disturbance over the Cancer Care Continuum
Pre-treatment
On Treatment (Surgery, Chemotherapy, Radiation Therapy, Endocrine Therapies)
Post-treatment and Long-Term Survivorship
Advanced Disease
Risk Factors for Sleep Disturbance in Cancer
Impact of Poor Sleep on Cancer and Its Treatment
Symptom Clusters
Screening and Assessing Sleep in Cancer Survivors
Treating Sleep Disturbances and Contributing Factors
Summary
References
Chapter 13: Insomnia in Comorbid Neurological Problems
Insomnia in Neurological Diseases (Degenerative and Others)
Insomnia and Dementia
Insomnia in Neurological Diseases with Motor System Involvement
Parkinson’s Disease (PD)
Dementia with Lewy Bodies (DLB)
Multiple System Atrophy (MSA)
Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD)
Huntington’s Disease (HD)
Progressive Dystonia
Tourette’s Syndrome (TS)
Autosomal Dominant Spinocerebellar Ataxia (SCA)
Insomnia and Sleep-Related Movement Disorders
Restless Legs Syndrome (RLS)
Periodic Limb Movements in Sleep (PLMS)
Propriospinal Myoclonus (PSM)
Nocturnal Frontal Lobe Epilepsy (NFLE)
REM Sleep Behavior Disorder (RBD)
Excessive Fragmentary Hypnic Myoclonus (EFHM)
Facio-Mandibular Myoclonus
Generalized Overactivity Syndrome (Agrypnia Excitata)
Fatal Familial Insomnia
Morvan Syndrome (MS)
Delirium Tremens (DT)
Agrypnia Excitata: A Generalized Activation Syndrome
References
Chapter 14: Insomnia in Psychiatric Disorders
Introduction
Depression
Bipolar Disorder
Anxiety Disorders
Generalized Anxiety Disorder
Panic Disorder
Posttraumatic Stress Disorder
Obsessive Compulsive Disorder
Attention-Deficit Hyperactivity Disorder
Schizophrenia and Psychotic Disorders
Substance-Use Disorders
Alcohol
Marijuana
Opiates
Nicotine
Caffeine
Stimulants
Conclusion
References
Index

People also search for (Ebook) Clinical Handbook Of Insomnia 3rd:

clinical handbook of insomnia
    
insomnia a clinical guide to assessment and treatment
    
handbook sleep disorders
    
insomnia clinical presentation
    
clinical guidelines insomnia
    
handbook of clinical hypnosis

Tags: Hrayr P Attarian, Insomnia, Clinical